Medtronic launches renal stent system in Europe:
This article was originally published in Clinica
Medtronic has launched its next-generation renal stent system, the Bridge X3, in Europe and other major markets outside the US. The device has a low crossing profile - it can be delivered through a 6 French sheath - it has high radial strength and has improved scaffolding due to having shorter element lengths, the company says. The product is not for sale in the US, where it is an investigational device.
You may also be interested in...
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.